Global X Genomics & Biotechnology ETF GNOM

Medalist Rating as of | See Global X Investment Hub

Morningstar’s Analysis GNOM

Will GNOM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Global X Genomics & Biotechnology ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GNOM

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 54.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

11.91 13M
Healthcare

Twist Bioscience Corp

6.26 7M
Healthcare

10x Genomics Inc Ordinary Shares - Class A

6.03 6M
Healthcare

Illumina Inc

5.87 6M
Healthcare

Natera Inc

5.61 6M
Healthcare

Guardant Health Inc

5.15 5M
Healthcare

Genscript Biotech Corp Class H

3.67 4M
Healthcare

Bio-Techne Corp

3.62 4M
Healthcare

Qiagen NV

3.40 4M
Healthcare

Vertex Pharmaceuticals Inc

3.35 4M
Healthcare

Sponsor Center